baber/WOPTO huggingface dataset:
Patent DE-69619966-D1 (DE)
Inventor: PIIRAINEN OLLI
IPC: H04L1/00
Filed: 1996-12-03
Granted: 2002-04-25
Abstract: PCT No. PCT/FI96/00646 Sec. 371 Date Aug. 1, 1997 Sec. 102(e) Date Aug. 1, 1997 PCT Filed Dec. 3, 1996 PCT Pub. No. WO97/21275 PCT Pub. Date Jun. 12, 1997A method and a receiver for forming transition metrics in the receiver of a digital cellular radio system. The receiver includes a hardware implementation of a transition metrics calculation unit for Viterbi decoding. The receiver includes a shift register for storing coefficients of a generator polynomial of a convolutional code. The receiver also includes masking means arranged to mask a state of the Viterbi decoding by the coefficients of the polynomial. The receiver has odd parity means arranged to form a parity bit of the state of the masked Viterbi decoding, the parity bit being arranged to control a block forming the transition metrics.
Patent DE-69626221-D1 (DE)
Inventor: RAMESH K
IPC: B29C48/18
Filed: 1996-10-07
Granted: 2003-03-20
Abstract: A heat-shrinkable backseamed casing film comprises a first layer, a second layer, and a third layer, with the first and third layers being outer layers and the second layer being between the first layer and the third layer. The first outer layer serves as an inside casing layer, and comprises polyolefin; the second layer comprises polyester and/or polyamide; the third layer serves as an outside casing layer and comprises polyolefin, polystyrene, and/or polyamide. The second layer has a thickness of at least about 5% of a total thickness of the heat-shrinkable casing film. Alternatively, the first layer comprises polyolefin and has a surface energy level of less than about 34 dynes/cm; the second layer comprises a polyamide having a melting point of at least 300° F.; and the third layer comprises polyolefin, polystyrene and/or polyamide. A package comprises a cooked meat product within the backseamed casing. The second layer of the casing film prevents or reduces necking down on the forming shoe during backseaming. The backseamed casing is especially useful for cook-in applications.
Patent DE-69631072-D1 (DE)
Inventor: SERRANO CECILE
IPC: C07C39/08
Filed: 1996-10-31
Granted: 2004-01-22
Abstract: PCT No. PCT/FR96/01722 Sec. 371 Date Aug. 31, 1998 Sec. 102(e) Date Aug. 31, 1998 PCT Filed Oct. 31, 1996 PCT Pub. No. WO97/16402 PCT Pub. Date May 9, 1997A method for C-alkylating a hydroxylated aromatic compound having at least one hydrogen atom in the ortho or para position relative to the hydroxyl grouping, wherein the aromatic compound is exposed to a proton acid and a compound causing the formation of a carbo-cation in the presence of the acid, and the reaction is performed in the presence of a solvent consisting of a water-alcohol pair.
Patent DE-69707313-D1 (DE)
Inventor: KONYA ARPAD
IPC: G06Q20/34
Filed: 1997-11-17
Granted: 2001-11-15
Abstract: A system is disclosed for transferring currency electronically between accounts. The system allows currency to be immediately transferred from a first account to a ATM. The first account can be accessed in a number of ways, including remotely from a general purpose computer or from an ATM using a transaction card. The ATM provides the individual with a plurality of transaction choices such as the transfer of an amount of currency to a second account. The ATM transmits information to a main computer regarding the second account and the amount of currency to be transferred. The main computer includes a database containing entry codes and routing codes for a plurality of banks belonging to the present electronic transfer network. Using this database, the main computer validates information such as the entry code for the banks and the availability of the second account prior to allowing the transaction to proceed. A transaction card associated with the second account is used to compare the recipient account to the account number provided by the sender. The transferred currency can then be retrieved using a second ATM. The transaction card is used solely to identify the recipient and currency is not actually transferred to the second account.
Patent DE-69718011-D1 (DE)
Inventor: BUECHLER FRANCIS
IPC: B01L3/00
Filed: 1997-08-25
Granted: 2003-01-30
Abstract: The invention relates to devices incorporating filters for filtering fluid samples, wherein the devices comprise means for region-specific compression of the filter, and uses thereof. <IMAGE>
Patent DE-69718842-D1 (DE)
Inventor: KINOSHITA NAOYUKI
IPC: C08L77/00
Filed: 1997-03-27
Granted: 2003-03-13
Abstract: A highly hygroscopic polyamide fiber formed from a polyamide composition containing a polyvinylpyrrolidone (in an amount of 3-15 wt%), which may be synthesized in isopropyl alcohol as a solvent, in which any pyrrolidone which may be present is present in an amount less than 0.1 wt%, and which polyvinylpyrrolidone has a K-value of 20-70. This fiber is characterised by a yellowness index lower than 10 before dying, a large difference between the maximum moisture absorptivity and the standard moisture absorptivity, and a low content of water-soluble components that are subject to leaching.
Patent DE-69724796-D1 (DE)
Inventor: GAST JAY
IPC: A61K31/57
Filed: 1997-07-23
Granted: 2003-10-16
Abstract: This invention provides a method of contraception which comprises administering to a female of child bearing age for 23-25 consecutive days, a first phase combination of a progestin at a daily dosage of 40-500  mu g trimegestone, 250  mu g - 4 mg dienogest, or 250  mu g - 4 mg drospirenone, and an estrogen at a daily dosage equivalent in estrogenic activity to 10-20  mu g ethinyl estradiol for 9-13 days beginning on day 1 of the menstrual cycle, wherein the same dosage of the progestin and estrogen combination is administered in each of the 9-13 days, and a second phase combination of a progestin at a daily dosage of 40-500  mu g trimegestone, 250  mu g - 4 mg dienogest, or 250  mu g - 4 mg drospirenone, and an estrogen at a daily dosage equivalent in estrogenic activity to 10-20  mu g ethinyl estradiol, for 11-15 days beginning on the day immediately following the last day of administration of the first phase combination, wherein the same dosage of the progestin and estrogen combination is administered in each of the 11-15 days, provided that the daily dosage of second phase progestin is greater than the daily dosage of the first phase progestin and that the daily dosage of the second phase estrogen is greater than or equal to the daily dosage of the first phase estrogen.
Patent DE-69732269-D1 (DE)
Inventor: WOJICK GUY
IPC: F28F3/02
Filed: 1997-06-02
Granted: 2005-02-24
Abstract: The efficiency of panel radiator for a central heating system is improved by a fin sheet (6) attached to the radiator panel terminating at a level (D) short of the headers (3) defined at the top and bottom of the panel so that the air ducts (9) defined by the fin sheet and the panel are not constricted at their ends. In addition the corrugations are shaped and dimensioned so that the ratio of the air flow area of the ducts to the circumference of the ducts (S1/L1) is related to the ratio of the flow area of air flow plenums on the side of the fin sheet remote from the panel, to the length of the plenum circumference defined by the fin sheet (S2/L2). <IMAGE>
Patent DE-69736667-D1 (DE)
Inventor: BECKER MCCLELLAN
IPC: C12Q1/6865
Filed: 1997-07-15
Granted: 2006-10-26
Abstract: The present invention concerns oligonucleotides containing one or more modified nucleotides which increase the binding affinity of the oligonucleotides to target nucleic acids having a complementary nucleotide base sequence. These modified oligonucleotides hybridize to the target sequence at a faster rate than unmodified oligonucleotides having an identical nucleotide base sequence. Such modified oligonucleotides include oligonucleotides containing at least one 2'-O-methylribofuranosyl moiety joined to a nitrogenous base. Oligonucleotides can be modified in accordance with the present invention to preferentially bind RNA targets. The present invention also concerns methods of using these modified oligonucleotides and kits containing the same.
Patent DE-69807924-D1 (DE)
Inventor: RUSSO ANTONELLO
IPC: A61J3/00
Filed: 1998-11-19
Granted: 2002-10-17
Abstract: A fluid transfer device connecting a medicinal vessel and an intravenous (IV) bag for enabling the mixing in closed system of the two products contained therein by means of a syringe, comprising a three-way plug valve assembly (3) with a first port ending in a connector (5) for a syringe, and a second and a third port (8, 7), each one provided into a respective spike (1, 2) connected to a housing (16, 17) for a container of medicinal product. Within the first one of the said two spikes (1) a further independent channel (13) is provided for the inlet and the outlet of air, communicating with the external environment through a hydrophobic filter (14). The second one of said two spikes (2) is capable of piercing the rubber closure of the injection point of a bag of medicinal product, and the corresponding housing (17) consists of two flexible arms (18, 19) fastenable to each other at the respective ends, so as to be tightened around the tube of the said injection point.
Patent DE-69812676-D1 (DE)
Inventor: HUTCHINGS RICHARD H
IPC: C07D211/76
Filed: 1998-10-09
Granted: 2003-04-30
Abstract: This invention relates a to a series of heterocyclic substituted piperazines of Formula Ipharmaceutical compositions containing them and intermediates used in their manufacture. The compounds of the invention selectively inhibit binding to the alpha-1a adrenergic receptor, a receptor which has been implicated in benign prostatic hyperplasia. As such the compounds are potentially useful in the treatment of this disease.
Patent DE-69835949-D1 (DE)
Inventor: LEVY GARY
IPC: A61K45/00
Filed: 1998-05-15
Granted: 2006-11-02
Abstract: Methods for mediating immune coagulation using novel antibodies and compounds are described. A protein Fgl2 having direct prothrombinase activity has been identified. Inhibitors of Fgl2 are useful in preventing and treating diseases which require a reduction in immune coagulation including bacterial and viral infections, allograft and xenograft rejection, glomerulonephritis, cancer, a number of gastrointestinal diseases and fetal loss.
Patent DE-69838800-D1 (DE)
Inventor: DANIEL JOHN M K
IPC: A61F2/02
Filed: 1998-03-04
Granted: 2008-01-10
Abstract: The present invention relates to (with reference to Figures 16A, 16B) a collapsible intravascular distal protection device for an emboli capturing system. It comprises a guidewire (194) having a distal tip, an expandable member (200;208) attached to the guidewire (194), a mesh (202;210) attached to the expandable member (200;208), and a sheath (204) having a cavity sized to receive and collapse the expandable member (200;208) and attached mesh (202;210). The guidewire (194) is slidingly received with the sheath (204) and the distal tip of the guidewire (194) may extend beyond the end of the sheath (204). The expandable member (200;208) when expanded has a diameter greater than the diameter the sheath (204). Starting with the expandable member (200;208) received in the sheath (204), moving the sheath (204) away from the expandable member (200;208) using the actuator wire (196) allows the expandable member (200;208) and attached mesh (202;210) to expand from a collapsed position to a deployed position.
Patent DE-69900299-D1 (DE)
Inventor: COLLIN NATHALIE
IPC: A61Q1/10
Filed: 1999-07-15
Granted: 2001-10-25
Abstract: A cosmetic or dermatological film-forming composition comprising a liquid fatty phase, including at least one volatile hydrocarbon oil, and a film-forming polymer in said liquid fatty phase, characterized in that it comprises at least one polyolefin wax resulting from the polymerization of alpha-olefins having at least 10 carbon atoms, said wax having a melting point ranging from 50 to 80° C. The invention includes the use of such a composition, especially for producing a water-resistant film exhibiting good hold with regard to rubbing, to tears, to perspiration or to sebum.
Patent DE-69907646-D1 (DE)
Inventor: ROURKE JAMES
IPC: A61K31/606
Filed: 1999-03-11
Granted: 2003-06-12
Abstract: The invention provides an absorbent article, at least a portion of which has a protease inhibitor incorporated therein to decrease the activity of proteases that may otherwise initiate or contribute to inflammation of the skin of a wearer of the article resulting in skin irritation or dermatitis. The article can further comprise a delivery system for releasably containing and delivering the protease inhibitor to at least a portion of the skin of the wearer. The delivery system can comprise a skin care composition and at least a portion of the composition, including the protease inhibitor, is automatically transferred from the article to the wearer's skin without manual intervention during normal usage of the article to form a defense against protease activity. Most preferably, repeated application of similarly treated articles to the wearer's skin provides an available source from which the protease inhibitor continuously transfers onto the skin over time and accumulates to provide a proactive defense against protease activity for the reduction or prevention of skin irritation or dermatitis due to proteolytic enzymes.
Patent DE-69908641-D1 (DE)
Inventor: HAYES JOHNATHAN
IPC: F41G9/00
Filed: 1999-12-10
Granted: 2003-07-10
Abstract: A combat pilot system for an aircraft comprises corresponding combat pilot devices 12, 12' provided in a runtime module 14 on board the aircraft and a ground-based system training module 16 respectively. The run-time module 12' is trained using model data generated simulation model 18 as well as feedback data from actual missile firings. The matrix of weights derived from the training routines are then programmed into the neural network in the corresponding combat pilot aid system 12 on board the aircraft so that the runtime module is capable of processing the input data producing the four parameters required for launch of a missile and also a FIRE/NO FIRE indication to the pilot.
Patent DE-69909646-D1 (DE)
Inventor: MORITA LTD
IPC: C07C229/34
Filed: 1999-11-17
Granted: 2003-08-21
Abstract: A process for producing a benzoylacrylic acid derivative (formula 1) in high yield through a small number of steps and a simple purification step. The process comprises reacting 2,4,5-trifluoro-3-methyl-6-nitrobenzoyl chloride with a compound (formula 2) to yield an aminoacrylic acid derivative (formula 1) and then reacting the aminoacrylic acid derivative (formula 1) with an amine derivative represented by R<2>-NH2, wherein R<2> is a cycloalkyl group or the like. <CHEM>   <CHEM>   <CHEM>
Patent DE-69912511-D1 (DE)
Inventor: GENNARO ANTONIO
IPC: B29C43/00
Filed: 1999-04-13
Granted: 2003-12-11
Abstract: Process for the preparation of end-products based on vinylaromatic polymers with a predominantly syndiotactic structure which comprises:     a) compressing the polymer in powder form in a mould at a pressure ranging from 0.1 to 500 Mpa; b) sintering the compressed powder, under pressure, at a temperature ranging from the glass transition temperature of the polymer (Tg) to 150 DEG C; c) slowly cooling the end-product to room temperature. c
Patent DE-69915124-D1 (DE)
Inventor: LANG ARNOLD
IPC: H04N7/16
Filed: 1999-12-23
Granted: 2004-04-01
Abstract: The present invention generally relates to systems for the management of programmes for home entertainment devices such as televisions. More particularly it is concerned with apparatus, methods and software for scheduling such programmes. <??>A method of gathering information for the programme database (76), the database comprising programme information for a plurality of programmes, including for each programme the programme start time, a real channel or programme source the programme is available from at that start time, and programme identification information; the method comprising:  i) accessing a web page; ii) storing the web page's uniform resource locator address; iii) searching the web page for information identifying a programme suitable for scheduling on the virtual channel and, if found, retrieving virtual channel schedule information for the programme, and adding the virtual channel schedule information to the programme database; iv) identifying a hypertext link from the web page to a new web page or, if none, returning to a previous web page until a link to a new Web page is found; and v) accessing the new web page and repeating steps (ii) to (iv).  <IMAGE>
Patent DE-69917149-D1 (DE)
Inventor: HUYGHE CHRISTIAN
IPC: A63C5/12
Filed: 1999-07-06
Granted: 2004-06-17
Abstract: The slide board comprises a central core (4), a slide block, ≥ 1 lower reinforcement layer and ≥ 1 upper reinforcement layer located on both sides of the board. An upper reinforcement layer is formed from two strips (10, 11) which are different in nature and extend onto each other from the central zone towards both ends. The strips (10, 11) are differentiated by the nature of the reinforcement material, or, in the case of 2 fiber-reinforced resin strips, by fiber orientation or weight. In the case of skis, the strips (10, 11) are superposed in the central zone of the board and reinforce the area of the ski where retaining elements are to be mounted.
Patent DE-69923565-D1 (DE)
Inventor: SAITO TETSURO
IPC: A47B47/00
Filed: 1999-11-10
Granted: 2005-03-10
Abstract: An interconnecting structure (20) for multiple members includes a stem portion, a first pair of legs (22a,22b) extending integrally from the stem portion in a first direction, the legs having sectional shapes matching those of grooves formed in opposite sides of a vertical panel and being formed at their tip portions with anchoring means (50), and a second pair of legs (22c,22d) extending integrally from the stem portion in a second direction perpendicular to the first direction, the legs having sectional shapes matching those of grooves formed in opposite sides of a lateral panel and being formed at their tip positions with anchoring means (50). The interconnecting structure (20) is used to interconnect the vertical panel and the lateral panel by inserting the first pair of legs (22a,22b) into the grooves of the vertical panel with the legs straddling the vertical panel and inserting the second pair of legs (22c,22d) into the grooves of the lateral panel with the legs straddling the lateral panel, thereby enabling the interconnector to make strong pressure contact with floors of the grooves of the vertical panel and the lateral panel through the anchoring means (50). <IMAGE>
Patent DE-69928267-D1 (DE)
Inventor: BONNEY STANLEY GEORGE
IPC: A61M16/00
Filed: 1999-08-26
Granted: 2005-12-15
Abstract: A dispenser for dispensing medicament comprising a housing having a support; a container, locatable within said housing, having an outlet member, wherein said container is movable relative to the housing to enable dispensing therefrom and said outlet member is connectable with said support to prevent relative movement therebetween; and a detector for tracking the relative proximity of the container to the housing, said detector comprising an inductive displacement transducer including one or more inductive elements, wherein said container is comprised of, or has attached thereto a component comprised of, a material capable of disturbing the magnetic field creatable by the flow of electric current in said one or more inductive elements, and related uses and methods.
Patent DE-69930739-D1 (DE)
Inventor: BECK VICTORIA
IPC: A61P25/28
Filed: 1999-06-09
Granted: 2006-05-18
Abstract: Secretin and secretin compositions are used for the treatment of autism and other neurological, behavioral and immunological disorders. The method includes administering an effective amount of secretin, such as Secretin-Ferring, to a patient. In one example, 2 clinical units (CU) of Secretin-Ferring was dissolved in a 7.5 ml solution of sodium chloride and was intravenously injected over 1 minute. In another example, secretin was administered transdermally by applying dimethyl sulfoxide (DMSO) to the patients skin and rubbing about 15 CU of Secretin-Ferring into the DMSO. Other methods and compositions for administering the effective amount of secretin include other transdermal carrier substances, such as gels, lotions, or patches; oral carriers, such as tablets, capsules, or lozenges; inhalation through the nose or mouth (e.g., as an aerosol); suppository forms of secretin and secretin compositions; and using acoustic waves to cause the secretin to penetrate the skin.
Patent DE-69933693-D1 (DE)
Inventor: MILLER ANDREW
IPC: H04M7/00
Filed: 1999-11-19
Granted: 2006-11-30
Abstract: Seamless transport of messages is provided between SS7 network elements and Internet Protocol (IP) network elements using an STP as an intermediary. Thus, messages may be routed between a first SP and a second SP via an STP using IP. Messages may be routed between an SP and an IP node via an STP using IP. Messages also may be routed between a first IP node and a second IP node via an STP using IP. Thus, the STP can be used as a vehicle for message transport among nodes of an SS7 network, among nodes of an IP network and between SS7 and IP networks. SS7 messages are bidirectionally communicated between an STP and at least one other SP of an SS7 network using IP, preferably TCP/IP. Preferably, SS7 messages are bidirectionally communicated between an STP and at least one SCP using IP. In particular, a first SS7 message that is received from the STP includes an SS7 Message Transfer Part (MTP) layer, an SS7 Signaling Connection Control Part (SCCP) layer and an SS7 Transaction Capability Application Part (TCAP) layer. The MTP layer (SS7 levels 1-3) is stripped from the first SS7 message. An IP routing layer is added to the SSCP layer and the TCAP layer that remain in the first SS7 message, to create a first IP message. The IP routing layer includes an IP address. The first IP message is transmitted to the IP address over an IP network. A second IP message is received from the IP network. The second IP message includes an SS7 SCCP layer, an SS7 TCAP layer and an IP routing layer. The IP routing layer is stripped from the second IP message to create a second SS7 message including an SS7 SCCP layer and an SS7 TCAP layer. The second SS7 message is then transferred to the STP.
Patent DE-502004001972-D1 (DE)
Inventor: GERSCHING DETLEV
IPC: D01F4/00
Filed: 2004-08-25
Abstract: Molded body comprises polymers which form a network produced from the chemical coupling of functional groups, hydrogen bridges or polymeric or oligomeric structures helically combined with each other. Up to 200 wt.% of a phase change material are embedded in the polymeric matrix. An independent claim is also included for a process for the production of the molded body.
Patent DE-502004002391-D1 (DE)
Inventor: KOENIG WALTER
IPC: B60N2/28
Filed: 2004-06-30
Abstract: A child seat ( 28 ) is described for mounting on a vehicle seat ( 10 ) which has a seat surface ( 16 ) which is inclined forward and upward in the direction of travel ( 18 ). The child seat ( 28 ) has a seat shell ( 32 ) which is arranged on a base part ( 30 ). The base part ( 30 ) has a base area ( 34, 36 ) which has a front base area section ( 34 ) and a rear base area section ( 36 ). The front and the rear base area sections ( 34 and 36 ) enclose an obtuse angle ( 38 ) with each other. A wedge element ( 40 ) bears either against the front or against the rear base area section ( 34 or 36 ), so that the wedge element ( 40 ) and the respective base area section ( 34 or 36 ) adjoining the wedge element ( 40 ) form a common level bearing surfaces ( 42 ).
Patent DE-502004003027-D1 (DE)
Inventor: ANGST PHILIPP
IPC: B66B3/00
Filed: 2004-11-05
Abstract: Multiple bus nodes are connected to associated one of sensors for sensing status information of the lift, such that each sensor controls application of voltage supply to the associated one of bus nodes. An independent claim is also included for monitoring system for lift.